コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 who received lymphoablative therapy prior to autologous hematopoietic stem cell transplantation.
2 plantation and 58 patients (2.7%) undergoing autologous hematopoietic stem cell transplantation.
3 .2 days (interquartile range, 10.5-124 d) in autologous hematopoietic stem cell transplantation.
4 ional high-dose therapy (C-HDT) (n = 98) and autologous hematopoietic stem cell transplantation.
5 f the procedure should improve outcome after autologous hematopoietic stem cell transplantation.
6 phalan-based chemotherapy, each supported by autologous hematopoietic stem-cell transplantation.
7 ation plus high-dose chemotherapy) and after autologous hematopoietic stem-cell transplantation.
8 erapy with cyclophosphamide and thiotepa and autologous hematopoietic stem-cell transplantation.
9 therapeutic dose of 166Ho-DOTMP followed by autologous hematopoietic stem cell transplantation 6 to
10 Autologous hematopoietic stem cell transplantation after
11 emia (t-MDS/AML) is a lethal complication of autologous hematopoietic stem-cell transplantation (aHCT
12 The reconstituting immune landscape after autologous hematopoietic stem-cell transplantation (AHSC
13 is myelosuppression, which might necessitate autologous hematopoietic stem-cell transplantation (AHSC
14 Adjuvant high-dose chemotherapy (HDC) with autologous hematopoietic stem-cell transplantation (AHST
15 ho received high-dose chemotherapy (HDC) and autologous hematopoietic stem-cell transplantation (ASCT
16 tic stem cell transplantation (alloHSCT) and autologous hematopoietic stem cell transplantation (auto
17 Patients undergoing autologous hematopoietic stem cell transplantation (auto
18 ymphoma who experience disease relapse after autologous hematopoietic stem cell transplantation (auto
19 pients of high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto
20 Autologous hematopoietic stem cell transplantation (auto
21 LVSD in adult lymphoma survivors (LSs) after autologous hematopoietic stem-cell transplantation (auto
22 features of this program help to explain how autologous hematopoietic stem cell transplantation can i
23 tem cell transplantation can be treated with autologous hematopoietic stem cell transplantation curre
24 kin's disease who underwent chemotherapy and autologous hematopoietic stem cell transplantation, foll
25 individuals after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for m
26 ng may be beneficial for patients undergoing autologous hematopoietic stem-cell transplantation for l
28 Autologous hematopoietic stem cell transplantation (HSCT
29 Autologous hematopoietic stem cell transplantation (HSCT
30 Autologous hematopoietic stem cell transplantation (HSCT
31 patients with hematologic cancers following autologous hematopoietic stem cell transplantation (HSCT
32 ncluding intensive chemotherapy (n = 121) or autologous hematopoietic stem cell transplantation (HSCT
33 tients with malignant hemopathies undergoing autologous hematopoietic stem cell transplantation (HSCT
34 In theory, maximum immune ablation by autologous hematopoietic stem cell transplantation (HSCT
35 d 46 patients with refractory SLE treated by autologous hematopoietic stem cell transplantation (HSCT
36 Clinical trials have indicated that autologous hematopoietic stem cell transplantation (HSCT
37 Autologous hematopoietic stem cell transplantation (HSCT
38 re treated by intense immune suppression and autologous hematopoietic stem cell transplantation (HSCT
39 Autologous hematopoietic stem cell transplantation (HSCT
40 Myeloablative autologous hematopoietic stem cell transplantation (HSCT
41 High-dose immunosuppressive therapy and autologous hematopoietic stem cell transplantation (HSCT
43 evidence that high-dose immune ablation and autologous hematopoietic stem cell transplantation in hu
44 nts with non-Hodgkin's lymphoma requiring an autologous hematopoietic stem-cell transplantation in fi
45 olongs the time to disease progression after autologous hematopoietic stem-cell transplantation in pa
46 g high-dose chemotherapy with bone marrow or autologous hematopoietic stem-cell transplantation in th
47 High-dose chemotherapy and autologous hematopoietic stem-cell transplantation shoul
48 The addition of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation to si
49 In patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation two p
50 Allogeneic and autologous hematopoietic stem-cell transplantations were
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。